-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Sabra Health Care REIT, Lowers Price Target to $21

Benzinga·10/13/2026 16:32:14
語音播報
Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-Weight and lowers the price target from $23 to $21.